Lyndon Foster is a life science executive with over 30 years of experience in research, business development, and leadership. He has held roles such as Chief Operating Officer and President/Owner of his own company. He has extensive expertise in areas such as molecular biology, neuroscience, and stem cell research. Throughout his career, he has successfully led technical operations and services teams, helping companies achieve substantial growth.
This document announces the 11th Annual Biosimilars UK conference taking place October 29-31, 2012 in London. It will bring together major pharmaceutical companies, regulatory bodies, CROs, CMOs, and law firms to discuss strategies for competing in the complex biosimilars market. Key topics will include the latest regulatory guidelines, financial viability, patent strategies, approval pathways, legal issues, preclinical/clinical challenges, the roles of the US and European markets, pricing/reimbursement, and pharmacovigilance. The goal is to help participants maximize opportunities in this changing landscape. Major sponsors include Merck Millipore and United BioSource Corporation.
A study on sales and promotion startegies towards Excellent Biotechnologies Muneer Mohammed
油
Excellent Biotechnologies is a leading biotech company in India that produces enzymes and chemicals. It aims to double its revenues to $50 million by 2020 by focusing on sales and promotion strategies. The biotech industry in India has experienced high growth of over 20% annually due to increasing investments, outsourcing, and government support. The future looks promising for the biotech sector to become a $100 billion industry by 2025.
SMi Group's Pre-filled Syringes East Coast 2019Dale Butler
油
This document provides an agenda for the Pre-Filled Syringes East Coast conference taking place April 8-10, 2019 in Boston. The conference will focus on the future of injectable drug delivery and feature speakers from pharmaceutical and device companies to discuss topics like regulations, connected devices, and patient-centricity. It will include presentations, panels, and workshops on developing combination products, human factors testing, digital health technologies, and more. Attendees can network and learn about the latest in pre-filled syringe development from industry experts.
The document is a corporate presentation that summarizes a company's mission, capabilities, and growth platforms. The company is a global leader in serving science with $10.5 billion in annual revenues. It provides analytical instruments, equipment, reagents, consumables, software and services to over 350,000 customers in research, analysis, discovery and diagnostics across many fields of science. The company focuses on areas like life sciences, diagnostics, environmental and safety applications through its analytical technologies in areas such as mass spectrometry, chromatography, and molecular spectroscopy.
A key source of growth in biologics over the next several years will be Biomanufacturing Ge Li, Chairman and CEO, Wuxi <outsourcing-pharma.com,>
Other issues with single-use include standardization of systems, the dependability to vendors, and the supply chain and waste management but if we can overcome extractables and leachables, we will eventually be able to scale up to many thousands of liters. Jason Li, Senior Director, Downstream Processing, Genor Biopharma <biopharma-reporter.com,>
Industry experts will discuss these and more at the 5th Annual Biomanufacturing Conference in Grand Hyatt Shanghai, China on 19 22 May 2015 during IBCs Biopharma Development & Production (BDP) Week.
2016 Thermo Fisher Scientific Company OverviewJosie Zheng
油
Thermo Fisher Scientific is the world leader in serving science, with 50,000 employees in 50 countries and $17 billion in annual revenues. It invests heavily in R&D and provides resources and opportunities for its employees to make significant contributions. The company has a balanced portfolio across consumables, instruments, services, and end markets. It aims to meet customer needs through innovative technologies and a global presence.
SMi Group's Prefilled Syringes West Coast 2019 conferenceDale Butler
油
This document provides information about a half-day post-conference workshop on June 5th, 2019 in San Diego, CA on identifying and addressing design flaws in medical devices before usability testing. The workshop will be led by Shannon Clark and will teach attendees principles of design, how to differentiate good and bad design through examples, and how to conduct expert reviews to uncover usability issues. Attendees will get hands-on experience reviewing prototypes and concepts to evaluate if they are optimized before testing. The workshop aims to help attendees learn how to identify design flaws early in the development process.
Mark Anthony Lewandowski has extensive experience in product development, project management, technical writing, and medical communication in the pharmaceutical industry. He has a PharmD degree and focuses on cardiovascular medicine and endocrinology. His career includes roles managing new product development, responding to medical information requests, and presenting on drug therapies.
In todays healthcare industry, medicine is becoming more and more personalized with patient focused approach. To drive such a personalized medicine avenue, Biomarker is a good example anda leading contract research organizations (CRO) like CMIC, Inc. have a responsibility to provide bioanalytical data meaningful enough for advanced medicines.
Allen Pierce is a highly collaborative global executive with over 25 years of experience driving revenue growth and operational excellence in life sciences, medical device, and high-tech industries. He has a track record of turning around businesses through strategic planning, organizational improvements, and operational efficiencies. Notable achievements include leading a $400M business turnaround and gaining three points of market share at Thermo Fisher Scientific.
A HIGHLY MOTIVATED PASSIONATE AND PROFESSIONAL LEADER with an expert knowledge in development of the new materials, sales, management staff, materials, process and applications.
Highly organized and results-oriented Supply Chain Executive with vast experience in fast-paced, highly complex environments of the Consumer and Medical Devices Industries. Exposure to global markets while managing highly sensitive cross-cultural interactions. Hand-on experience in business requirement analysis to align SC strategy to Business strategy. Leadership experience managing projects and standardization of new processes. Strong background in Operations (Project Management, S&OP, Demand Planning, Inventory Management, Procurement, Contracts Management, Supplier Strategic Alliances & Supplier Quality Audits, Quality Assurance & Regulatory Compliance). Strong communication and people skills. Computer literate performer in Microsoft Office Excel Macros, SAP, APS, APO, and JDE Demantra among others. Fully Bilingual in English and Spanish.
This document provides information about an upcoming biobanking conference to take place on March 10-11, 2011 in London. It lists key speakers from companies like AstraZeneca, Bayer, and Sanofi-Aventis who will discuss topics like sample storage, biomarker discovery, and stem cell banking. The document also notes the growing market for biobanking and its importance for medical research. Sponsoring companies and media partners promoting the conference are also listed.
CPL Executive Search is a recruitment and business development consultancy specializing in finding skilled professionals for the life science industry. With over 21 years of experience and a global network of over 23,000 contacts, CPL has successfully found candidates with rare skill combinations to fill roles in food, cosmetics, healthcare, and other sectors. CPL offers clients a unique service including customized searches, regular updates, anonymity if desired, and repeat business from satisfied customers.
SMi Group's 3rd annual Biosimilars North America 2016Dale Butler
油
This document provides information about the "3rd Annual Conference on Biosimilars North America" event happening on November 15-17, 2016 in Iselin, New Jersey. It includes details about pre-conference workshops, the speaker lineup, and session topics which will address regulatory considerations, commercialization strategies, and technological developments for biosimilars in the US. Registration discounts are offered before June 30th and September 30th. The event is aimed at solving challenges and accelerating commercialization of biosimilars in North America.
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...Merry D'souza
油
The 10 most innovative pharma and biotech solution providers, 2020 september 2020; Insights Success has published The 10 most innovative pharma and biotech solution providers.
5th Annual Pre-Filled Syringes East CoastTeri Arri
油
This document provides an agenda for the Pre-Filled Syringes East Coast conference taking place on April 10-12, 2018 in Boston. The agenda includes workshops on human factors for connected drug delivery systems and design considerations for drug delivery outside the clinic on April 10th. The main conference on April 11-12th will feature sessions on regulatory updates, manufacturing challenges and solutions, trends toward biologics, and human factors considerations. Speakers will address topics such as syringe filling of high concentration formulations, safety evaluation of leachables, quality by design principles, and the future of digital monitoring biomarkers.
Whats NEW in 2015s program?
More case studies on successful commercialization
Insights on developing biosimilars under new CFDA guideline
Emerging business models in regulated and developing markets
New and timely topics on:
o Valuating biosimilars investments
o Successful technology transfer
o Key criteria in gaining approval
Also, NEW Expert Faculty includes:
Dr Shin Jae Chang, Vice President, Celltrion, Korea
Ira Jacobs, Global Oncology Lead, Biosimilars, Pfizer, US
Paul Thomas, Business Unit Head Biosimilars, Biocon, India
Dr. Martina A. Sersch, Global Clinical Lead, Oncology Global Development, APAC Biotherapeutics Lead, Genentech, Inc. / F. Hoffmann-La Roche Ltd.
Raj Kannan, Vice President, Commercial Head, Biosimilars, Merck, Switzerland
Huiguo (Forrest) Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co., Ltd, China
Ko Chung Lin, Chief Executive Officer, PharmaEssentia Corporation, Taiwan
Wen Yong, Vice Director, Drug Research Institutes, Biopharmaceutical Institute, Jiangsu AoSaiKang Pharmaceutical Co Ltd, China
http://www.biosimilarsasia.com
This document is an announcement for the Biobanking Americas conference to be held from November 9-11, 2010 in Boston. The conference will bring together experts in biobanking including scientists, regulators, and researchers to discuss practical knowledge and strategic advice on biobanking models and frameworks. Key topics will include best practices for biobank resources, challenges in biorepository management, applications of genome sequencing, the future of biobanks, regulation, ethics, investment, and humanization of drug discovery. Speakers will provide insights into tissue and data bioprospecting, quality management, and benchmarking biobanking practices. The conference is aimed at VPs, directors, and managers of biobanks, tissue banks
The pharmaceutical industry is facing challenges developing new drugs due to limited knowledge of biology and chemistry. There are only about 500 validated drug targets and 9,500 known chemical compounds. The industry has relied on developing oral small-molecule drugs but is running out of viable targets and compounds. To succeed in the future, companies will need to accelerate target validation, invest more in new areas like genomics and proteomics, broaden their portfolios, and increase collaboration with external partners to gain expertise in areas like biologics development.
Quality metrics approach is indeed building up the foundation of culture of quality in pharmaceutical manufacturing operations. This is a practical navigation appearing on global radar and will rule all around in the same manner on the principle of similarity in human physiology irrespective of geographical locations. Strengthening the quality system will strengthen the culture of quality both in business of pharmaceutical manufacturing and regulations.
Dan Rocco has over 20 years of experience in sales and marketing in the healthcare industry. He has a proven track record of exceeding sales goals and growing account portfolios. Currently he works as a Sales Representative for a molecular and cancer diagnostics company, developing new business opportunities and presenting to various diagnostic businesses. Previously he held senior sales and marketing roles at several companies, managing territories and product lines and routinely ranking as a top sales performer.
AAIPharma Services is a leading provider of drug development and manufacturing services located in Wilmington, NC. The company is seeking a Sr. Director of Formulations Development to lead a group providing formulation development and clinical trial material manufacturing. Key responsibilities include developing the business, overseeing formulation design and scale up, managing projects and client relationships, and ensuring regulatory compliance. The ideal candidate has over 10 years of experience developing biopharmaceutical products and a track record of managing scientific teams.
This document is a resume for Christie Anderer, an animal health sales professional with over 16 years of experience exceeding sales targets. She has a proven track record of sales success launching new products and implementing marketing strategies. Her most recent role is a Sales Executive at Parnell, where she introduced new products and drove adoption of a digital marketing tool.
Lee Ann Norton has over 20 years of experience in sales and marketing in the chemical and environmental industries. She has consistently increased sales revenue and expanded product markets while working as a Sales Account Manager at Univar USA. Prior to that, she worked as the Director of External Relations for the Pharmaceutical and Chemical Sciences Graduate Program at University of the Pacific, where she successfully recruited students and secured internships. Norton has a track record of technical, analytical, and organizational abilities along with the skills to work effectively independently or as part of a team.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
SMi Group's Prefilled Syringes West Coast 2019 conferenceDale Butler
油
This document provides information about a half-day post-conference workshop on June 5th, 2019 in San Diego, CA on identifying and addressing design flaws in medical devices before usability testing. The workshop will be led by Shannon Clark and will teach attendees principles of design, how to differentiate good and bad design through examples, and how to conduct expert reviews to uncover usability issues. Attendees will get hands-on experience reviewing prototypes and concepts to evaluate if they are optimized before testing. The workshop aims to help attendees learn how to identify design flaws early in the development process.
Mark Anthony Lewandowski has extensive experience in product development, project management, technical writing, and medical communication in the pharmaceutical industry. He has a PharmD degree and focuses on cardiovascular medicine and endocrinology. His career includes roles managing new product development, responding to medical information requests, and presenting on drug therapies.
In todays healthcare industry, medicine is becoming more and more personalized with patient focused approach. To drive such a personalized medicine avenue, Biomarker is a good example anda leading contract research organizations (CRO) like CMIC, Inc. have a responsibility to provide bioanalytical data meaningful enough for advanced medicines.
Allen Pierce is a highly collaborative global executive with over 25 years of experience driving revenue growth and operational excellence in life sciences, medical device, and high-tech industries. He has a track record of turning around businesses through strategic planning, organizational improvements, and operational efficiencies. Notable achievements include leading a $400M business turnaround and gaining three points of market share at Thermo Fisher Scientific.
A HIGHLY MOTIVATED PASSIONATE AND PROFESSIONAL LEADER with an expert knowledge in development of the new materials, sales, management staff, materials, process and applications.
Highly organized and results-oriented Supply Chain Executive with vast experience in fast-paced, highly complex environments of the Consumer and Medical Devices Industries. Exposure to global markets while managing highly sensitive cross-cultural interactions. Hand-on experience in business requirement analysis to align SC strategy to Business strategy. Leadership experience managing projects and standardization of new processes. Strong background in Operations (Project Management, S&OP, Demand Planning, Inventory Management, Procurement, Contracts Management, Supplier Strategic Alliances & Supplier Quality Audits, Quality Assurance & Regulatory Compliance). Strong communication and people skills. Computer literate performer in Microsoft Office Excel Macros, SAP, APS, APO, and JDE Demantra among others. Fully Bilingual in English and Spanish.
This document provides information about an upcoming biobanking conference to take place on March 10-11, 2011 in London. It lists key speakers from companies like AstraZeneca, Bayer, and Sanofi-Aventis who will discuss topics like sample storage, biomarker discovery, and stem cell banking. The document also notes the growing market for biobanking and its importance for medical research. Sponsoring companies and media partners promoting the conference are also listed.
CPL Executive Search is a recruitment and business development consultancy specializing in finding skilled professionals for the life science industry. With over 21 years of experience and a global network of over 23,000 contacts, CPL has successfully found candidates with rare skill combinations to fill roles in food, cosmetics, healthcare, and other sectors. CPL offers clients a unique service including customized searches, regular updates, anonymity if desired, and repeat business from satisfied customers.
SMi Group's 3rd annual Biosimilars North America 2016Dale Butler
油
This document provides information about the "3rd Annual Conference on Biosimilars North America" event happening on November 15-17, 2016 in Iselin, New Jersey. It includes details about pre-conference workshops, the speaker lineup, and session topics which will address regulatory considerations, commercialization strategies, and technological developments for biosimilars in the US. Registration discounts are offered before June 30th and September 30th. The event is aimed at solving challenges and accelerating commercialization of biosimilars in North America.
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...Merry D'souza
油
The 10 most innovative pharma and biotech solution providers, 2020 september 2020; Insights Success has published The 10 most innovative pharma and biotech solution providers.
5th Annual Pre-Filled Syringes East CoastTeri Arri
油
This document provides an agenda for the Pre-Filled Syringes East Coast conference taking place on April 10-12, 2018 in Boston. The agenda includes workshops on human factors for connected drug delivery systems and design considerations for drug delivery outside the clinic on April 10th. The main conference on April 11-12th will feature sessions on regulatory updates, manufacturing challenges and solutions, trends toward biologics, and human factors considerations. Speakers will address topics such as syringe filling of high concentration formulations, safety evaluation of leachables, quality by design principles, and the future of digital monitoring biomarkers.
Whats NEW in 2015s program?
More case studies on successful commercialization
Insights on developing biosimilars under new CFDA guideline
Emerging business models in regulated and developing markets
New and timely topics on:
o Valuating biosimilars investments
o Successful technology transfer
o Key criteria in gaining approval
Also, NEW Expert Faculty includes:
Dr Shin Jae Chang, Vice President, Celltrion, Korea
Ira Jacobs, Global Oncology Lead, Biosimilars, Pfizer, US
Paul Thomas, Business Unit Head Biosimilars, Biocon, India
Dr. Martina A. Sersch, Global Clinical Lead, Oncology Global Development, APAC Biotherapeutics Lead, Genentech, Inc. / F. Hoffmann-La Roche Ltd.
Raj Kannan, Vice President, Commercial Head, Biosimilars, Merck, Switzerland
Huiguo (Forrest) Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co., Ltd, China
Ko Chung Lin, Chief Executive Officer, PharmaEssentia Corporation, Taiwan
Wen Yong, Vice Director, Drug Research Institutes, Biopharmaceutical Institute, Jiangsu AoSaiKang Pharmaceutical Co Ltd, China
http://www.biosimilarsasia.com
This document is an announcement for the Biobanking Americas conference to be held from November 9-11, 2010 in Boston. The conference will bring together experts in biobanking including scientists, regulators, and researchers to discuss practical knowledge and strategic advice on biobanking models and frameworks. Key topics will include best practices for biobank resources, challenges in biorepository management, applications of genome sequencing, the future of biobanks, regulation, ethics, investment, and humanization of drug discovery. Speakers will provide insights into tissue and data bioprospecting, quality management, and benchmarking biobanking practices. The conference is aimed at VPs, directors, and managers of biobanks, tissue banks
The pharmaceutical industry is facing challenges developing new drugs due to limited knowledge of biology and chemistry. There are only about 500 validated drug targets and 9,500 known chemical compounds. The industry has relied on developing oral small-molecule drugs but is running out of viable targets and compounds. To succeed in the future, companies will need to accelerate target validation, invest more in new areas like genomics and proteomics, broaden their portfolios, and increase collaboration with external partners to gain expertise in areas like biologics development.
Quality metrics approach is indeed building up the foundation of culture of quality in pharmaceutical manufacturing operations. This is a practical navigation appearing on global radar and will rule all around in the same manner on the principle of similarity in human physiology irrespective of geographical locations. Strengthening the quality system will strengthen the culture of quality both in business of pharmaceutical manufacturing and regulations.
Dan Rocco has over 20 years of experience in sales and marketing in the healthcare industry. He has a proven track record of exceeding sales goals and growing account portfolios. Currently he works as a Sales Representative for a molecular and cancer diagnostics company, developing new business opportunities and presenting to various diagnostic businesses. Previously he held senior sales and marketing roles at several companies, managing territories and product lines and routinely ranking as a top sales performer.
AAIPharma Services is a leading provider of drug development and manufacturing services located in Wilmington, NC. The company is seeking a Sr. Director of Formulations Development to lead a group providing formulation development and clinical trial material manufacturing. Key responsibilities include developing the business, overseeing formulation design and scale up, managing projects and client relationships, and ensuring regulatory compliance. The ideal candidate has over 10 years of experience developing biopharmaceutical products and a track record of managing scientific teams.
This document is a resume for Christie Anderer, an animal health sales professional with over 16 years of experience exceeding sales targets. She has a proven track record of sales success launching new products and implementing marketing strategies. Her most recent role is a Sales Executive at Parnell, where she introduced new products and drove adoption of a digital marketing tool.
Lee Ann Norton has over 20 years of experience in sales and marketing in the chemical and environmental industries. She has consistently increased sales revenue and expanded product markets while working as a Sales Account Manager at Univar USA. Prior to that, she worked as the Director of External Relations for the Pharmaceutical and Chemical Sciences Graduate Program at University of the Pacific, where she successfully recruited students and secured internships. Norton has a track record of technical, analytical, and organizational abilities along with the skills to work effectively independently or as part of a team.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
CJR Advisors provides strategic marketing and commercial assessment consulting services. Charlie Raffin is the president and has over 30 years of experience in various roles within Johnson & Johnson, including vice president positions assessing new products and developing global marketing strategies. He has extensive leadership experience in the pharmaceutical and diagnostic industries.
Simon C. Lord has over 30 years of global business experience in the life sciences industry. He currently serves as the Director of Marketing and Product Development at MBD Industries, where he has developed 9 new algae-based products and prepared business plans. Prior to this role, Lord held several leadership and marketing roles at BASF and Cognis, where he exceeded sales targets and successfully negotiated new contracts worth over $8 million. Lord has a Graduate Diploma in Biotechnology from the University of Melbourne and a Bachelor of Science with Honors in Biochemistry from Monash University.
Pamela Appleton has over 25 years of experience in healthcare as a registered nurse and clinical informatics leader, with expertise in project management, strategic sales, and implementing new healthcare technologies. She has held roles such as project manager at Moffitt Cancer Center and clinical analyst for Community Health Systems, leading initiatives to improve workflows and implement new software. The document outlines her educational background, areas of expertise, professional profile including roles and responsibilities, and highlights her success in exceeding sales goals and leading teams to outstanding results.
Mark Koeppel has over 15 years of experience in technical applications and field support roles. He has a PhD in Pharmacology and Toxicology and has trained customers on techniques like next-generation sequencing, RNA extraction, and amplification. Currently he works for HTG Molecular Diagnostics providing hands-on training, presentations, troubleshooting, and technical support to customers.
This proposal outlines a strategy to build a $80-150 million revenue company that manufactures and distributes fine chemical and biologic products. The plan involves acquiring several complementary companies and integrating their operations to achieve efficiencies and expand sales and marketing globally. The life science industry is large, complex, and fragmented, creating opportunities to consolidate segments profitably. The proposal discusses targeting small companies for acquisition and leveraging the proposing team's experience in operations and industry knowledge to increase acquired companies' profitability through direct distribution and other means.
David Pritchard is an experienced biomedical executive who has held leadership roles in business development, licensing, clinical development planning, and strategic consulting. He has founded several biotech companies and negotiated numerous deals between academic institutions, biotechs, and large pharmaceutical companies. Pritchard has over 30 years of experience in the industry globally and provides strategic advisory services to clients.
Professional Resume for Celine Boudreaux-McCaddon (6)Celine McCaddon
油
Celine Boudreaux-McCaddon is a senior pharmaceutical sales specialist with over 20 years of experience in the pharmaceutical industry. She has a proven track record of successfully launching new products and achieving sales goals. Her expertise includes new product launches, market analysis, strategic planning, and relationship building with physicians and healthcare providers. She has received numerous awards for her sales achievements and contributions to her former employer, Endo Pharmaceuticals, where she was consistently a top performer.
T. Chad Barton has over 10 years of experience in product management and technical support roles in the medical device field. He currently works as a Southern California Business Manager for HemoCue, where he manages a high priority $1.8 million sales territory. Previously, he was a Technical Product Manager at Quest Diagnostics, where he oversaw five product lines and led global initiatives. Barton has a background in biochemistry and is proficient in various business software.
Aryn Mayor provides concise career summaries and resume writing services. Her experience includes positions in staffing, marketing, and as the owner of her own career consulting business. She shares best practices for resume elements, what to include and avoid, and tips for selling oneself to employers through accomplishment-focused content.
Marc Hollingworth Director Of Sales And Marketing Resume Mmpeterh
油
Marc Hollingworth is an accomplished sales and marketing executive with over 20 years of experience launching medical devices and pharmaceutical products. He has increased sales by 65% and revenues exceeding $400 million. Hollingworth holds an MBA and has expertise in business planning, new business development, team management, and financial acumen. He has worked for companies in ophthalmology, medical devices, and pharmaceuticals.
Mark Prodger is a highly experienced senior business leader with expertise in strategic planning, product development, market research, and talent development. He has over 20 years of experience leading initiatives to drive growth at various Fortune 500 companies. Most recently, he provided consultative services and led projects to develop robust client information processes at Midwest ISO.
Ramiro Salinas Jr. is seeking a position in the environmental sciences field where he can utilize his education and experience. He has over 15 years of experience in various roles related to environmental science, laboratory testing, and sales. His experience includes positions at Halliburton, United Laboratories, USDA, Abaxis, and Fisher Scientific where he conducted testing, sales, customer support, and training. He also has experience working as an environmental scientist and teaching high school physics.
Michael Buckley has over 25 years of experience in biotech developing monoclonal antibodies and antibody drug conjugates for oncology and immunology indications. He has held leadership roles at multiple biotech companies, directing preclinical and clinical development programs. Currently, he works as an independent consultant focusing on preclinical development and manufacturing of biologics from Phase I through commercial stage.
This summary provides an overview of Stuart Allan Murray's background and experience in the biopharmaceutical industry over the past 25+ years. Murray has extensive experience leading commercial strategies for anti-infective products from early development through genericization. Most recently, he has been the president of his own consulting firm advising on product planning, commercialization, and optimizing asset value throughout the lifecycle. Prior to that, he held several leadership roles at Cubist Pharmaceuticals leading major product franchises and functions.
1. 1
A forward-thinking bioscience professional with proven leadership, scientific, and business skills. A key
strategic thinker with over 30+ years of experience in life science research discovery, problem solving, solution
building, strategic marketing and new product road mapping and development experience. A scientific technical
expert with working knowledge of all major research platforms, methods, and technologies. A consummate life
scientist and teacher, recognized for his ability to build positive and productive relationships across all levels of
an organization.
Scientific Expertise:
Expert life scientist, life science trainer, technical director, and executive.
Created and lead top tier technical and customer service organizations for major companies such as
Millipore, Serologicals, Upstate and Chemicon International.
Managed and lead research and IVD technical product teams serving 200M+/yr product lines with
15,000+ products and services.
Educated in many areas of life science including Neuroscience, Cell Biology, protein trafficking and
ubiquitination, apoptosis/autophagy, cellular aging, MMP & extracellular matrix, stem cell and
developmental biology.
Familiar and have performed research in a wide variety of biological systems and platforms from basic
research to drug discovery and diagnostics, cell based assays to DNA amplification and analysis.
Well skilled in viral IVD diagnostic support, IVD filings,
Highly skilled molecular biologist and cellular biologist; extensive experience in DNA/RNA
manipulation/extraction, all molecular cloning methods, PCR and nucleic acid hybridization assays;
strong experience in eukaryotic gene cloning, expression & protein analysis in diverse systems.
In vitro & in vivo cell culture (eukaryotic, prokaryotic, mammalian, CNS, stem cell), trans-plantation,
protein analysis detection methods, ELISA, Luminex, flow cytometry, immuno-histochemistry, and most
other common life science methodologies.
Over 30 years of molecular & cellular biology science experience; 15 publications, 3 patents, multiple
academic, research, and teaching honors.
Professional Work Experience:
CHIEF OPERATING OFFICER, (COO), Biosensis Limited, North American Operations, Oceanside, CA. 2012-
continuing.
Hired to lead, coordinate, and help operate all aspects sales, technical, web, and marketing support of
Biosensis Limiteds expansion in to the US Life Science Market.
Operates, maintains and achieved 400K in sales targets for 2012-2014
On target for 500K in sales and a sustained growth of >15% for 2015 financial year.
PRESIDENT, OWNER, LMF Biosciences, Oceanside California, 2011 continuing
Founded LMF Biosciences, currently 100-200K small business operation
Provides life science reagent and diagnostic technical support, scientific consulting, technical writing,
content marketing, warehouse, and customer wisdom activities to small to medium sized life science
reagent companies worldwide.
DIRECTOR, Symansis Limited, North American Warehouse and Customer Care Center, Temecula CA, 2010-
continuing
Established and operates US product warehouse for Symansis Limited which serves as shipment and
product support hub for Symansis Limiteds 300K life science research reagent business worldwide.
Manages worldwide distributors, customer orders, marketing and sales needs for Symansis Limiteds
worldwide life science reagent business focused on cell signaling and small molecule inhibitors.
Oceanside, CA 92056, (760) 525-2660
lmfbiosciences@gmail.com ; LinkedIn: Lyndon Foster
http://www.linkedin.com/in/lyndonmfoster
Lyndon M Foster, MS., Ph.D.
Life science executive and scientist
2. Lyndon M Foster, MS., Ph.D. 2015
2
Provides warehouse management, stocking and shipping services for Symansis Limited worldwide.
Provides Technical, Website, Marketing, Tradeshow and Sales support for Symansis Limited worldwide
SENIOR MANAGER TECHNICAL SERVICES, Millipore Corporation, Temecula, California; 2006-09.
Successfully lead worldwide Technical Service teams and the Technical Content Marketing teams for all
research and diagnostic reagents developed within the Millipore Temecula Life Sciences Division
supporting a 200M dollar annual business.
Headed up IVD Diagnostic customer complaint and investigation teams for 14-18M Light Diagnostic速
IVD products sold by Chemicon, Serologicals, and Millipore.
Played a crucial role in the success of multiple bio-reagent companies (i.e. Chemicon, & Serologicals;
rising from a 100M firm in 2004 to a 1.2B sale in 2006) by providing world-class scientific, technical, and
customer support expertise.
Assisted the Company in recovering and sustaining a >10% increase in market share in the Bio-reagent
supply business by leading our world-class technical services organization and providing the superior
technical product support, new product vision, and customer solution discovery that is so critical for
success in this market segment.
Key member of Temecula Leadership Team and used leadership, analysis, and problem-solving skills to
lead a positive shift in culture, build sustainable manufacturing processes and ultimately make the
business profitable again.
Team lead for numerous bio-manufacturing, logistics, and R&D troubleshooting investigations that
supported multiple product lines and sales of upward to 60M a year.
Worked closely with marketing to create and edit numerous technical product literature pieces, posters,
pathway designs in both paper and web formats for our 80K person customer base.
Deeply involved in new product development & product road-mapping, review and release.
Successfully developed and managed the technical service and customer handling procedures needed
for the integration of Guava Technologies into the Life Science Divisions responsibilities.
Developed, trained, and mentored direct reports and scientists across the organization.
SENIOR DIRECTOR OF TECHNICAL INFORMATION SERVICES, Serologicals-Upstate/Chemicon ,
Temecula, California; 2002-06.
Played an instrumental role in the financial success of the Companys research reagent and diagnostic
businesses by providing the technical expertise to customers, sales, and marketing for all 15,000
products and this contributed toward moving a 100 million dollar business to a 1.2 billion dollar sale to
Millipore Corporation in 2006.
Successfully managed customer service and its transition to the SAP productivity software by providing
the kind of positive environment leadership, mentoring, and can do attitude necessary to get the most
of my employees even when circumstances are difficult.
Developed, edited and managed the maintenance of the technical product information, technical
product posters, and technical marketing literature for some 15,000 research and IVD diagnostic
products
Managed and lead the technical and language component of the CE certification project for EU
certification of the 18M/yr IVD Light Diagnostics速 product line for the company
Directed the Technical Services Department for the US and three WW Company locations. Managed
18-20 individuals in the US, 4 abroad, with six direct reports.
CHIEF TECHNICAL OFFICER, Chemicon International, Inc., Temecula, California; 2000-02.
Established a best-in-class technical services group at Chemicon that created a perception of quality
about Chemicon and engendered a culture of customer service and excellence throughout the
Company.
3. Lyndon M Foster, MS., Ph.D. 2015
3
Successfully managed and lead the technical service component, customer training and IVD complaint
process for Chemicon IVD Light Diagnostics速 line of viral and pathogen detection products.
Successfully managed the technical incorporation, literature and product support materials for 7M dollar
purchase of Roche bio-reagents leading to >10% growth in product revenue.
Successfully managed the technical incorporation and customer support for 14M dollar purchase of
ESGRO/LIF from AMRAD which lead to a vast increase in product revenue through the sale and
support LIF for mouse embryonic stem cells and their culture.
Employee of the year, 2002.
MANAGER, TECHNICAL SERVICES, Chemicon International Inc., Temecula California; 1998-2000.
Created, developed and managed the technical services department for Chemicon International.
Demonstrated the necessary employee positive and customer-first environment necessary to build and
maintain a successful, information intensive, service intensive business.
Employee of the year, 1999.
SENIOR SCIENTIST III, ChromaXome Corporation, San Diego, California; 1996-98.
Creator and manager of the eukaryotic molecular biology group for the Company
Co-author of ChromaXomes key patents and provider of much of its vision for the future.
A Combinatorial Biology pioneer, contributed to the 4.5M value proposition of the Company.
Education:
Senior Post-Doctoral Research Scientist, Dr. Dale Bredesen, Apoptosis & Program on Aging,
Burnham Institute, La Jolla, California.
Post Doctoral Research Scientist, Dr. A.T. Campagnoni, Oligodendrocyte research, University of
California, Los Angeles.
Ph.D., MS., Biology/Molecular Cell Biology, University of California, Santa Barbara, Santa Barbara
California.
B.Sc., Biology, Minor Philosophy, Loyola Marymount University, Los Angeles California.
Honors:
3 Millipore Thank you Awards, Purchasing, Manufacturing, and Quality Departments, Millipore
Temecula, 2008.
Leader of Best Technical Service Organization, Biocompare 2007 customer survey. Biocompare,
2007.
Leadership Excellence Award, Leadership Academy; Serologicals Corporation, Temecula CA, 2004.
Special Recognition Award, Sales Department, Chemicon International Inc., Temecula, CA, 2000.